05
Pharmaceutical preparations for the treatment of various
diseases, namely, rare diseases, genetic disorders, chronic
liver diseases, cardiovascular diseases, cancers, and viral
infections; oligonucleotide compounds for use in the
targeted delivery of RNAI therapy; pharmaceutical
preparations for use in targeted pharmaceutical therapies
for the treatment of various diseases, namely, rare
diseases, genetic disorders, chronic liver diseases,
cardiovascular diseases, cancers, and viral infections;
chemical preparations for pharmaceutical or medicinal use in
the form of a molecular nanoparticle complex that
facilitates the delivery of RNA-based drugs to biological
cells; drug delivery agents consisting of oligonucleotide
compounds that facilitate the delivery of a wide range of
pharmaceutical based therapies
42
Research and development of oligonucleotide compounds for
use in targeted pharmaceutical therapies for the treatment
of various diseases, namely, rare diseases, genetic
disorders, chronic liver diseases, cardiovascular diseases,
cancers, and viral infections; research and development of
pharmaceutical preparations for the treatment of liver-based
disorders; research and development of oligonucleotide
compounds for targeted gene silencing; scientific research
and development; scientific investigations for medical
purposes; providing medical and scientific research
information in the field of pharmaceuticals and clinical
trials